Novo Nordisk inks purchase deal for Prothena’s ATTR amyloidosis program
July 12 2021 - 7:31AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Sep 2023 to Sep 2024